Copied to clipboard!
Spectrum and significance of MYC and BCL2 mutations in DLBCL
We analyzed the spectrum and clinical significance of MYC and BCL2 mutations in 347 DLBCL cases from population-based cohort of BC, Canada. Mutational status of MYC and BCL2 coding exons were sequenced using TSCA assay.
- Type: Other
- Archiver: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001003140 | Illumina MiSeq | 347 |
| Publications | Citations |
|---|---|
|
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma.
EJHaem 3: 2022 764-774 |
3 |